These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28526148)

  • 1. Cardiovascular Pharmacology: An Update and Anesthesia Considerations.
    Asgarian C; Liu H; Kaye AD
    Anesthesiol Clin; 2017 Jun; 35(2):273-284. PubMed ID: 28526148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular pharmacology: an update.
    Liu H; Fox CJ; Zhang S; Kaye AD
    Anesthesiol Clin; 2010 Dec; 28(4):723-38. PubMed ID: 21074748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of recent cardioactive and vasoactive drugs in anesthesia.
    Viets JL; Blades KA; Mitchell ND; Perez WE
    Nurse Anesth; 1990 Mar; 1(1):21-32. PubMed ID: 2285711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cardiovascular medications in the elderly.
    Ali Raza J; Movahed A
    Int J Cardiol; 2002 Oct; 85(2-3):203-15. PubMed ID: 12208585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
    Zordoky BN; Robertson IM; Dyck JR
    Biochim Biophys Acta; 2015 Jun; 1852(6):1155-77. PubMed ID: 25451966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular pharmacologic therapies under investigation: 2012.
    Frishman WH; Pallerla K
    Cardiol Rev; 2012; 20(3):102-10. PubMed ID: 22301717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transversus abdominis plane block in combination with general anesthesia provides better intraoperative hemodynamic control and quicker recovery than general anesthesia alone in high-risk abdominal surgery patients.
    Tsuchiya M; Takahashi R; Furukawa A; Suehiro K; Mizutani K; Nishikawa K
    Minerva Anestesiol; 2012 Nov; 78(11):1241-7. PubMed ID: 23132262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology in the post-blockbuster era.
    Brandes RP
    Curr Opin Pharmacol; 2010 Apr; 10(2):109-10. PubMed ID: 20202904
    [No Abstract]   [Full Text] [Related]  

  • 9. Grapefruit-drug interactions.
    Straughan JL
    Cardiovasc J S Afr; 2007; 18(1):39-40. PubMed ID: 17392996
    [No Abstract]   [Full Text] [Related]  

  • 10. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
    Rosano GM; Lewis B; Agewall S; Wassmann S; Vitale C; Schmidt H; Drexel H; Patak A; Torp-Pedersen C; Kjeldsen KP; Tamargo J
    Eur Heart J; 2015 Oct; 36(40):2677-80. PubMed ID: 25948737
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular Medications in Pregnancy: A Primer.
    Florio KL; DeZorzi C; Williams E; Swearingen K; Magalski A
    Cardiol Clin; 2021 Feb; 39(1):33-54. PubMed ID: 33222813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone for the treatment of cardiovascular disorders.
    Watanabe M; Krum H
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):831-8. PubMed ID: 22908915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of cardiovascular side effects with anti-anginal drugs.
    Rousan TA; Mathew ST; Thadani U
    Expert Opin Drug Saf; 2016 Dec; 15(12):1609-1623. PubMed ID: 27659354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacology of agents used to manage cardiovascular instability during general anaesthesia in small animals.
    Norman WM; Dodman NH; Seeler DC; Court MH
    Br Vet J; 1988; 144(1):5-20. PubMed ID: 3345417
    [No Abstract]   [Full Text] [Related]  

  • 15. Omapatrilat: a unique new agent for the treatment of cardiovascular disease.
    Nawarskas JJ; Anderson JR
    Heart Dis; 2000; 2(3):266-74. PubMed ID: 11728268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 2.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):7-9. PubMed ID: 19127495
    [No Abstract]   [Full Text] [Related]  

  • 17. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 1.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):5-6. PubMed ID: 19127494
    [No Abstract]   [Full Text] [Related]  

  • 18. Abstracts of the 10th International Congress on Cardiovascular Pharmacotherapy. Kyoto, Japan, 27-31 March 2001.
    Cardiovasc Drugs Ther; 2001 Mar; 15 Suppl 1():1-166. PubMed ID: 11501560
    [No Abstract]   [Full Text] [Related]  

  • 19. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.
    Wu JW; Boudreau DM; Park Y; Simonds NI; Freedman AN
    Expert Opin Drug Saf; 2014 Aug; 13(8):1071-99. PubMed ID: 24999107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving current goals in prevention and treatment of vascular disease: an update.
    Catapano AL; Elisaf MS; Florentin M; Mikhailidis DP; Kostapanos MS
    Curr Pharm Des; 2013; 19(21):3749-52. PubMed ID: 23286439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.